Facebook Linkedin Twitter
Inside Precision Medicine Landmark Study Reveals Elevated Ovarian Cancer Risk for Women with Severe Endometriosis

Endometriosis

Endometriosis, 3D illustration
News & Features

Landmark Study Reveals Elevated Ovarian Cancer Risk for Women with Severe Endometriosis

Alisa Kirkin -
0
Women with chronic pelvic pain prescribed gabapentin sitting on the couch holding stomach area.
News & Features

Genetic Variant Determines Response to Gabapentin in Chronic Pelvic Pain

Helen Albert -
0
DNA molecule with sparkling effects
Molecular Dx

Opportunities in Omics Integration

Kathy Vuksanaj -
0
Three beautiful young women looking various directions
News & Features

Breaking Down Barriers to Improve Women’s Health

Helen Albert -
0
Endometriosis, 3D illustration
News & Features

PrecisionLife Licenses Endometriosis Data to Create Personalized Treatments

Anita Chakraverty -
0
Endometriosis, 3D illustration
Molecular Dx

Feinstein Researchers Developing Non-Invasive Endometriosis Diagnostic

Chris Anderson -
0
uterus and ovaries
News & Features

Genetic Cause of Endometriosis Points to New Drug Target

Malorye Branca -
0
Endometriosis, 3D illustration
News & Features

Epigenetic Changes in Reproductive Cells Could Help Diagnose Endometriosis

Helen Albert -
0
With $10M in Series A Financing, DotLab Plans Further Development of Endometriosis Test
News & Features

With $10M in Series A Financing, DotLab Plans Further Development of Endometriosis Test

Alex Philippidis -
0
A study by researchers at Yale School of Medicine has concluded that progesterone receptor (PR) levels are an important predictor of whether women with endometriosis will respond to first-line
News & Features

Biomarkers Predict Responsiveness to First-Line Treatment for Endometriosis

Inside Precision Medicine Staff Writer -
0

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine